Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.

PLoS One · 2015 · PMC4444019 · PMID 26010758

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Wild-type mice treated with anatabine at a dosage of 10 and 20 mg/Kg/Day showed a trend for spending more time in the opens arms of the elevated plus maze but this effect was not statistically significant (Figs 2D and 3D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.